2022 American Transplant Congress

TOPIC: Clinical Science » Liver » 60 - Liver: MELD Allocation*

18 Month Impact of the National Liver Review Board
J. Foutz¹, S. Noreen¹, K. Bradbrook², M. Cafarella¹, J. Pomposelli³, S. Biggins⁴, J. Trotter⁵
18 Month Review of Liver Acuity Circles Allocation
J. Foutz¹, S. Noreen¹, M. Cafarella¹, A. Wilk¹, J. Trotter², S. Biggins³, J. Pomposelli⁴
Allocation Based on Acuity Circles Decreases Waiting Time for Liver Transplant Patients
M. H. Kim, K. Sasaki, A. Gallo, T. Pham, M. L. Melcher, S. Busque, C. Esquivel, C. Bonham
Center-Level Variability in DDLT Rate Before and After the Implementation of MMaT/250 Score
T. Ishaque, J. Beckett, B. King, J. G. Wang, D. Segev, A. Massie
Designing Continuous Distribution for Liver Allocation
M. Mankowski¹, N. Wood², D. Segev³, S. Gentry²
Disparities in Liver Transplant Access for HCC Patients Based on Patient Blood Type and the Intensity of Competition for Organs Under MMAT-3
A. J. Ahearn, H. Chowdhry, J. L. Dodge, K. Zhou
Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0?
A. Kwong, A. Mannalithara, W. Kim
Failure to Account for Social Determinants of Health in Non-HCC MELD Exceptions Exacerbates Geographic Disparities in Access to Liver Transplantation
R. M. Cannon, P. MacLennan, S. S. Sheikh, B. J. Orandi, A. Nasell, J. T. Walker, J. E. Locke
Impact of MMaT Policy on Transplant for Hepatocellular Carcinoma at a Single Center
S. Kodali¹, D. W. Victor², J. Corkrean², A. Shetty², C. Mobley², M. Hobeika², R. McMillan², E. A. Graviss³, D. T. Nguyen³, R. McFadden⁴, V. Ankoma-Sey², C. Egwim⁵, J. Galati², A. Saharia², R. M. Ghobrial²
Liver Transplantation Outcomes for Budd-Chiari Syndrome in the MELD Era
S. A. Alqahtani¹, C. Schneider², O. Sims³, A. Gurakar⁴, H. Tamim⁵, A. Bonder⁶, B. Saberi⁶